Eyenovia Inc (NAS:EYEN)
$ 0.78 0.01 (1.3%) Market Cap: 42.02 Mil Enterprise Value: 50.14 Mil PE Ratio: 0 PB Ratio: 19.50 GF Score: 21/100

Eyenovia Inc Pipeline Update Conference Call Transcript

Oct 29, 2019 / 09:00PM GMT
Release Date Price: $3.02 (-5.63%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Eyenovia Pipeline Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Tram Bui from The Ruth Group.

Tram Bui
The Ruth Group, Inc. - SVP

Good afternoon and welcome to Eyenovia's conference call and audio webcast. With me today are Dr. Sean Ianchulev, Eyenovia's Chief Executive Officer and Chief Medical Officer; John Gandolfo, Eyenovia's Chief Financial Officer; and Michael Rowe, Eyenovia's Vice President of Commercial.

Earlier this afternoon, Eyenovia issued a press release announcing the advancement of its micro line program for the treatment of presbyopia for Phase III development and the reprioritization of its late-stage ophthalmology pipeline. We encourage everyone to read today's press release as well as the supplementary materials Eyenovia filed with the SEC.

In addition, this conference call is being webcast through

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot